SARS-CoV-2 IgG Detection Kit (Colorimetric Anti-Spike S1 RBD IgG detection)

Catalog #
79985
$590 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The SARS-CoV-2 IgG detection kit is designed for qualitative detection of human IgG antibodies in serum collected from individuals suspected of prior infection with the virus that causes COVID-19. This fast and simple ELISA uses the receptor binding domain (RBD) of the SARS-CoV-2 Spike protein (BPS Bioscience #100696) to identify IgG antibodies that indicate a previous infection with SARS-CoV-2. 

This product has been cited 1 time.

Synonyms
SARS-CoV-2 RBD IgG detection kit, spike RBD kit, anti-spike IgG
Product Info
Storage and Usage
Citations1
Assay Kit Format
Colorimetric
Supplied As
The SARS-CoV-2 IgG Detection Kit (Colorimetric Anti-Spike S1 RBD IgG detection) Detection Kit comes in a convenient 96-well format, with purified SARS-CoV-2 RBD protein and an HRP-conjugated anti-human Fc antibody for 100 binding reactions.
Materials Required But Not Supplied

PBS (Phosphate buffered saline)
PBST (Phosphate buffered saline containing 0.05% Tween-20)
Dry Milk (Fisher #115668 or compatible)
1N HCl (aqueous)
Rotating or rocker platform
UV/Vis spectrophotometer microplate reader capable of reading absorbance at 450 nm

Format
Catalog
Number

Component

Amount

Storage
100696 Spike S1 RBD, Avi-His tag (SARS-CoV-2) 5 µg -80°C

Avoid
multiple
freeze/
thaw
cycles!
  anti-human Fc-HRP conjugate (1 mg/ml) 5 µl +4°C
  Colorimetric HRP substrate 10 ml +4°C
79964 Transparent 96-well microplate 1 Room
Temp
 

*The initial concentration of Spike RBD is lot-specific and will be indicated on the tube containing the protein

UniProt #
P0DTC2 SPIKE_WCPV
Background

The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and binds to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection.

References

Long, Q.-X., et al. 2020. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. (in press). https://doi.org/10.1038/s41591-020-0897-1